title: [Analysis of liver function in patients with Turner syndrome (TS) and in patients with secondary hypogonadism with estrogen and estrogen- progestagens replacement therapy: a preliminary report].
abstract: OBJECTIVE
  Abnormalities of liver function tests were been reported in adults with TS and in patients with oestrogen replacement therapy.
  
  
  METHODS
  The aim of this study was to evaluate the prevalence of liver disease in patients before or with oestrogen therapy.
  
  
  METHODS
  79 patients, aged 13(2/12) to 60(4/12), for oestrogen replacement therapy: 13--with secondary hypogonadism (group I), 29--with TS (group II), 19--with menopause (group IV) and 18--with TS, aged 2 to 16(11/12), before oestrogen therapy (group III).
  
  
  METHODS
  All patients were tested for liver function tests (ALAT, GGTP, total bilirubin), and patients I-III groups for serum markers of HBV and HCV infection.
  
  
  RESULTS
  The frequency of HBV/HCV infection was 38.3% in group I, 13.7%--in group II, 16.7%--in group III. In 13.7% patients of group II and in 16.7% patients of group III the liver disease had been classified as cryptogenic.
  
  
  CONCLUSIONS
  The prevalence of HBV/HCV infection in patients with hypogonadism and the prevalence of cryptogenic liver disease in patients with TS, seems to be relatively high. In TS liver function test should be investigated as well before oestrogen therapy and should be turned during the follow up.
authors.affiliation: Kliniki Gastroenterologii i Zywienia, Instytutu Pomnik-Centrum Zdrowia Dziecka w Warszawie.
authors.forename: J
authors.initials: J
authors.lastname: Rujner
authors.forename: A
authors.initials: A
authors.lastname: Dabrowska-Jakubiak
authors.forename: A
authors.initials: A
authors.lastname: Wiśniewski
authors.forename: M
authors.initials: M
authors.lastname: Szypulska
authors.forename: T
authors.initials: T
authors.lastname: Jakubiak
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D007006:Hypogonadism / Q000097:blood* / Q000209:etiology / Q000628:therapy*; D008111:Liver Function Tests; D008593:Menopause / Q000502:physiology; D015995:Prevalence; D011372:Progestins / Q000627:therapeutic use*; D014424:Turner Syndrome / Q000097:blood* / Q000150:complications; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D011372:Progestins; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase; D001663:Bilirubin